1,374 results on '"Sargent, Daniel J"'
Search Results
202. Identifying Verticillium dahliae Resistance in Strawberry Through Disease Screening of Multiple Populations and Image Based Phenotyping
203. Is the predictive and prognostic impact of sporadic and familial microsatellite instable stage III colon cancer different? A pooled analysis of the PETACC8 and NCCTG N0147 (Alliance) trials.
204. The radial distance of extraprostatic extension of prostate carcinoma: implications for prostate brachytherapy
205. Comparative analysis of rosaceous genomes and the reconstruction of a putative ancestral genome for the family
206. Genome-wide SNP identification by high-throughput sequencing and selective mapping allows sequence assembly positioning using a framework genetic linkage map
207. The development and characterisation of a bacterial artificial chromosome library for Fragaria vesca
208. A genetic linkage map of Venturia inaequalis, the causal agent of apple scab
209. Synteny conservation between two distantly-related Rosaceae genomes: Prunus (the stone fruits) and Fragaria (the strawberry)
210. Identifying Verticillium dahliae resistance in strawberry through disease screening of multiple populations and image based phenotyping
211. Method for evaluating prediction models that apply the results of randomized trials to individual patients
212. Book World: Overlooked architect of the Cold War
213. Mapping of A1 conferring resistance to the aphid Amphorophora idaei and dw (dwarfing habit) in red raspberry (Rubus idaeus L.) using AFLP and microsatellite markers
214. The Shock of the Global : The 1970s in Perspective
215. A Roundtable on Thomas Schwartz, Henry Kissinger and American Power: A Political Biography.
216. Ronald Reagan, Human Rights Champion?
217. Richard Nixon and Europe: The Reshaping of the Postwar Atlantic World Nichter Luke A.
218. Global Rules: America, Britain, and a Disordered World Cronin James S.
219. A Three-Outcome Design for Phase II Clinical Trials
220. PHASE II STUDY OF PACLITAXEL AND CISPLATIN FOR ADVANCED UROTHELIAL CANCER
221. An adaptive multi-stage phase I dose-finding design incorporating continuous efficacy and toxicity data from multiple treatment cycles
222. Physical Activity and Outcomes in Patients with Stage III Colon Cancer: A Correlative Analysis of Phase III Trial NCCTG N0147 (Alliance)
223. Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
224. Immunoscore to provide prognostic information in low- (T1-3N1) and high-risk (T4 or N2) subsets of stage III colon carcinoma patients treated with adjuvant FOLFOX in a phase III trial (NCCTG N0147; Alliance).
225. Chapter 13 - Statistics and Clinical Trials
226. Reporting of patient characteristics and stratification factors in phase 3 trials investigating first-line systemic treatment of metastatic colorectal cancer : A systematic review
227. Prognostic value of primary tumour resection in synchronous metastatic colorectal cancer : Individual patient data analysis of first-line randomised trials from the ARCAD database
228. Reporting of patient characteristics and stratification factors in phase 3 trials investigating first-line systemic treatment of metastatic colorectal cancer: A systematic review
229. Prognostic value of primary tumour resection in synchronous metastatic colorectal cancer: Individual patient data analysis of first-line randomised trials from the ARCAD database
230. Personalizing survival predictions in advanced colorectal cancer: The ARCAD nomogram project
231. Combining Survival and Toxicity Effect Sizes from Clinical Trials: NCCTG 89-20-52 (Alliance)
232. Sample Size and Design Considerations for Phase II Clinical Trials with Correlated Observations
233. Rehabilitating an underestimated strategic thinker: Zbigniew Brzezinski
234. American Joint Committee on Cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicine
235. Alcohol consumption and colon cancer prognosis among participants in North Central Cancer Treatment Group phase III trial N0147
236. Programmatic and Pragmatic Approaches for Quality of Life Measurement
237. The new Cambridge history of American foreign relations, vol. 4: challenges to American primacy, 1945 to the present Warren I. Cohen
238. Identification of powdery mildew resistance QTL in Fragaria x ananassa
239. Altered regulation of TERMINAL FLOWER 1 causes the unique vernalisation response in an arctic woodland strawberry accession
240. Repeated measures dose-finding design with time-trend detection in the presence of correlated toxicity data
241. Prospective pooled analysis of six phase III trials investigating duration of adjuvant (adjuv) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with stage III colon cancer (CC): The IDEA (International Duration Evaluation of Adjuvant chemotherapy) collaboration.
242. A hierarchical Bayesian design for randomized Phase II clinical trials with multiple groups
243. Association of immune markers and Immunoscore with survival of stage III colon carcinoma (CC) patients (pts) treated with adjuvant FOLFOX: NCCTG N0147 (Alliance).
244. Randomized trial of FOLFOX alone or combined with atezolizumab as adjuvant therapy for patients with stage III colon cancer and deficient DNA mismatch repair or microsatellite instability (ATOMIC, Alliance A021502).
245. Analysis of serum vitamin D levels and prognosis in stage III colon carcinoma patients treated with adjuvant FOLFOX+/- cetuximab chemotherapy: NCCTG N0147 (Alliance).
246. Assessing outcome differences in the second line treatment of metastatic colorectal cancer (mCRC): An ARCAD analysis comparing sequence after first line trials (SAFL) and dedicated second line trials (DSLT).
247. Impact of overall severity of adverse events (AEs) on long-term outcomes in metastatic colorectal cancer (mCRC) patients (pts) treated with first line systemic chemotherapy: Findings from 3,971 pts in the ARCAD database.
248. Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline Summary From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology
249. Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology
250. Association of DNA Mismatch Repair and Mutations in BRAF and KRAS With Survival After Recurrence in Stage III Colon Cancers
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.